Penumbra (PEN) EPS (Weighted Average and Diluted) (2014 - 2026)
Penumbra (PEN) reported EPS (Weighted Average and Diluted) of $0.82 for Q1 2026, down 18.0% year-over-year from $1.0 in Q1 2025, and down 31.67% quarter-over-quarter from $1.2 in Q4 2025.
Penumbra (PEN) EPS (Weighted Average and Diluted) (2014 - 2026) Analysis & Trends
Penumbra (PEN) has 13 years of EPS (Weighted Average and Diluted) data on file, last reported at $0.82 in Q1 2026.
- EPS (Weighted Average and Diluted) for Q1 2026 came in at $0.82, down 18.0% year-over-year; the trailing twelve-month figure through Mar 2026 was $4.34 (up 305.61% YoY), and the FY2025 annual result was $4.52, up 1155.56% from the prior year.
- EPS (Weighted Average and Diluted) declined to $0.82 in Q1 2026 per PEN's latest filing, from $1.2 in the prior quarter.
- Over five years, EPS (Weighted Average and Diluted) peaked at $1.38 in Q4 2023 and troughed at -$1.55 in Q2 2024.
- A 5-year average of $0.47 and a median of $0.48 in 2023 frame the typical range for EPS (Weighted Average and Diluted).
- The sharpest annual moves came in 2023 and 2024: EPS (Weighted Average and Diluted) jumped 10679.63% in 2023, then sank 422.92% in 2024.
- A 5-year view of EPS (Weighted Average and Diluted) shows it stood at $0.1 in 2022, then surged by 1280.0% to $1.38 in 2023, then plunged by 36.96% to $0.87 in 2024, then soared by 37.93% to $1.2 in 2025, then slumped by 31.67% to $0.82 in 2026.
- Business Quant data shows PEN's EPS (Weighted Average and Diluted) at $0.82 in Q1 2026, $1.2 in Q4 2025, and $1.17 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Weighted Avg. Diluted) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 0.61 |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 1.93 |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 0.89 |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 0.90 |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 0.66 |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 0.51 |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 0.85 |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 2.24 |
| 10 | Penumbra | 12.45 Bn | 11.84 Bn | 253.41 Mn | 0.82 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.82 |
| Dec 31, 2025 | 1.20 |
| Sep 30, 2025 | 1.17 |
| Jun 30, 2025 | 1.15 |
| Mar 31, 2025 | 1.00 |
| Dec 31, 2024 | 0.87 |
| Sep 30, 2024 | 0.75 |
| Jun 30, 2024 | -1.55 |
| Mar 31, 2024 | 0.28 |
| Dec 31, 2023 | 1.38 |
| Sep 30, 2023 | 0.23 |
| Jun 30, 2023 | 0.48 |
| Mar 31, 2023 | 0.22 |
| Dec 31, 2022 | 0.10 |
| Sep 30, 2022 | -0.06 |
| Jun 30, 2022 | -0.10 |
| Mar 31, 2022 | 0.00 |
| Dec 31, 2021 | -0.66 |
| Sep 30, 2021 | 0.24 |
| Jun 30, 2021 | 0.25 |